Clinical Trial Update: Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating EN3835 for plantar fibromatosis (Ledderhose disease) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ledderhose Disease
• Plantar Fibromatosis

Drugs mentioned

• EN3835

Snippet

Sponsor: Endo USA Inc., a Keenova Therapeutics Company | Conditions: Plantar Fibromatosis, Ledderhose Disease | Phase 3 | Status: COMPLETED